The long-term goal of this proposal is to establish the mechanisms of ethanol (EtOH)-induced cancer in which chronic alcohol consumption with physiologically relevant doses stimulates tumor angiogenesis and matigancy. Alcohol consumption is a well-established risk factor for various types of cancer, such as cancers of the oral cavity, esophagus, liver, and breast. However, the mechanisms of EtOH-induced cancer are not clear. Growth and expansion of tumor mass are strictly dependent upon the sustained formation of new blood vessels, a process termed angiogenesis. Vascular endothelial growth factor (VEGF) is one of the most important angiogenic factors, which is markedly up-regulated in the vast majority of human tumors. We have recently reported in Am J Physiology that physilogically relevant levels of EtOH induce VEGF expression and angiogenesis in both models of cell culture and chick chorioallantoic membrane (CAM). Furthermore, we have discovered that EtOH treatment with physiologically relevant doses increases intratumoral vascularity and VEGF expression while enhancing tumor progression and intravasantion of cancer cells in a chick CAM model. These findings suggest that EtOH-induced angiogenesis represents an important mechanism of cancer progression associated with chronic alcohol consumption in humans. We will use chronic alcohol in vivo models with administration of hysiologically relevant doses of EtOH that mimics chronic alcohol consumption in humans. This proposed work will test the hypothesis that chronic alcohol consumption with physiologically relevant loses can mediate angiogenic factors and drive a system of positive feedback between the expanding neoplasm and vasculature, wherein each promotes the growth of the other. We will use different models to address the following specific aims: 1) whether EtOH treatment with physiologically relevant doses can stimulate tumor angiogenesis and tumor progression in both in vivo models of the CAM, nude and scid mice; 2) whether administration of EtOH can alter the expression of VEGF and other regulatory factors of angiogenesis in the tumor, the circulation, and the cultured cells; and 3) how EtOH treatment can play a role in a system of positive feedback between intratumoral vasculature and tumor mass. The new information will promote cancer prevention and treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AA013821-02
Application #
6942781
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Purohit, Vishnu
Project Start
2004-09-01
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
2
Fiscal Year
2005
Total Cost
$148,000
Indirect Cost
Name
University of Mississippi Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Makey, Kristina L; Patterson, Sharla G; Robinson, James et al. (2013) Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women. Eur J Cancer Prev 22:83-9
Gu, Jian-Wei; Young, Emily; Patterson, Sharla G et al. (2011) Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice. Cancer Biol Ther 11:910-7
Young, Emily; Miele, Lucio; Tucker, Kevan B et al. (2010) SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells. Cancer Biol Ther 10:703-11
Gu, Jian-Wei; Young, Emily; Busby, Brandi et al. (2009) Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice. Cancer Biol Ther 8:514-21
Gu, Jian-Wei; Manning Jr, R Davis; Young, Emily et al. (2009) Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 297:R142-8
Gu, Jian-Wei; Bailey, Amelia P; Tan, Wei et al. (2008) Long-term High Salt Diet Causes Hypertension and Decreases Renal Expression of Vascular Endothelial Growth Factor in Sprague-Dawley Rats. J Am Soc Hypertens 2:275-285
Tan, Wei; Bailey, Amelia P; Shparago, Megan et al. (2007) Chronic alcohol consumption stimulates VEGF expression, tumor angiogenesis and progression of melanoma in mice. Cancer Biol Ther 6:1211-7
Gu, Jian-Wei; Tian, Niu; Shparago, Megan et al. (2006) Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 291:R1817-24
Gu, Jian-Wei; Shparago, Megan; Tan, Wei et al. (2006) Tissue endostatin correlates inversely with capillary network in rat heart and skeletal muscles. Angiogenesis 9:93-9
Bailey, Amelia Purser; Shparago, Megan; Gu, Jian-Wei (2006) Exercise increases soluble vascular endothelial growth factor receptor-1 (sFlt-1) in circulation of healthy volunteers. Med Sci Monit 12:CR45-50

Showing the most recent 10 out of 11 publications